The Toronto Star interviewed Filament CEO Ben Lightburn about our development of medical grade ayahuasca for the first time and how it could treat conditions like PTSD and substance use disorder.
Recent News
A Canadian psychedelic drug company has created medical grade ayahuasca
The Toronto Star
December 4, 2022
